Somatostatin receptor based hybrid imaging in sarcoidosis

Riemer H J A Slart; Klaas-Pieter Koopmans; Peter Paul van Geel; Henk Kramer; Harry J M Groen; C Tji-Joong Gan; Niek H J Prakken; Andor W J M Glaudemans; George D Nossent

doi:10.1186/s41824-017-0014-y

Somatostatin receptor based hybrid imaging in sarcoidosis

Riemer H J A Slart, Klaas-Pieter Koopmans, Peter Paul van Geel, Henk Kramer, Harry J M Groen, C Tji-Joong Gan, Niek H J Prakken, Andor W J M Glaudemans, George D Nossent

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

224 Downloads (Pure)

Abstract

Several diagnostic imaging methodologies are available for the clinical evaluation of sarcoidosis, but all have their limitations. FDG PET/CT is frequently used, but this technique does not provide optimal results in all cases. Novel radiopharmaceuticals aimed at other disease targets may be helpful, particularly in cardiac sarcoidosis when FDG PET/CT has a low diagnostic accuracy, due to difficulties in preparing the patients who should use a specific diet combined with prolonged fasting. 68Ga-labeled somatostatin based receptor hybrid imaging is a potential alternative to FDG PET/CT. This short communication provides a rapid overview of initial findings concerning the application of 68Ga-labeled somatostatin based receptor hybrid imaging in the diagnosis of (cardiac) sarcoidosis activity.

Original language	English
Article number	7
Number of pages	5
Journal	European Journal of Hybrid Imaging
Volume	1
DOIs	https://doi.org/10.1186/s41824-017-0014-y
Publication status	Published - 15-Dec-2017

Access to Document

10.1186/s41824-017-0014-yLicence: CC BY

Somatostatin receptor based hybrid imaging in sarcoidosisFinal publisher's version, 507 KBLicence: CC BY

Cite this

@article{df9819755af64a88b5819e061691ce8f,

title = "Somatostatin receptor based hybrid imaging in sarcoidosis",

abstract = "Several diagnostic imaging methodologies are available for the clinical evaluation of sarcoidosis, but all have their limitations. FDG PET/CT is frequently used, but this technique does not provide optimal results in all cases. Novel radiopharmaceuticals aimed at other disease targets may be helpful, particularly in cardiac sarcoidosis when FDG PET/CT has a low diagnostic accuracy, due to difficulties in preparing the patients who should use a specific diet combined with prolonged fasting. 68Ga-labeled somatostatin based receptor hybrid imaging is a potential alternative to FDG PET/CT. This short communication provides a rapid overview of initial findings concerning the application of 68Ga-labeled somatostatin based receptor hybrid imaging in the diagnosis of (cardiac) sarcoidosis activity.",

author = "Slart, {Riemer H J A} and Klaas-Pieter Koopmans and {van Geel}, {Peter Paul} and Henk Kramer and Groen, {Harry J M} and Gan, {C Tji-Joong} and Prakken, {Niek H J} and Glaudemans, {Andor W J M} and Nossent, {George D}",

year = "2017",

month = dec,

day = "15",

doi = "10.1186/s41824-017-0014-y",

language = "English",

volume = "1",

journal = "European Journal of Hybrid Imaging",

issn = "2510-3636",

publisher = "Springer",

}

Somatostatin receptor based hybrid imaging in sarcoidosis. / Slart, Riemer H J A; Koopmans, Klaas-Pieter; van Geel, Peter Paul; Kramer, Henk; Groen, Harry J M ; Gan, C Tji-Joong ; Prakken, Niek H J ; Glaudemans, Andor W J M; Nossent, George D.

In: European Journal of Hybrid Imaging, Vol. 1, 7, 15.12.2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Somatostatin receptor based hybrid imaging in sarcoidosis

AU - Slart, Riemer H J A

AU - Koopmans, Klaas-Pieter

AU - van Geel, Peter Paul

AU - Kramer, Henk

AU - Groen, Harry J M

AU - Gan, C Tji-Joong

AU - Prakken, Niek H J

AU - Glaudemans, Andor W J M

AU - Nossent, George D

PY - 2017/12/15

Y1 - 2017/12/15

N2 - Several diagnostic imaging methodologies are available for the clinical evaluation of sarcoidosis, but all have their limitations. FDG PET/CT is frequently used, but this technique does not provide optimal results in all cases. Novel radiopharmaceuticals aimed at other disease targets may be helpful, particularly in cardiac sarcoidosis when FDG PET/CT has a low diagnostic accuracy, due to difficulties in preparing the patients who should use a specific diet combined with prolonged fasting. 68Ga-labeled somatostatin based receptor hybrid imaging is a potential alternative to FDG PET/CT. This short communication provides a rapid overview of initial findings concerning the application of 68Ga-labeled somatostatin based receptor hybrid imaging in the diagnosis of (cardiac) sarcoidosis activity.

AB - Several diagnostic imaging methodologies are available for the clinical evaluation of sarcoidosis, but all have their limitations. FDG PET/CT is frequently used, but this technique does not provide optimal results in all cases. Novel radiopharmaceuticals aimed at other disease targets may be helpful, particularly in cardiac sarcoidosis when FDG PET/CT has a low diagnostic accuracy, due to difficulties in preparing the patients who should use a specific diet combined with prolonged fasting. 68Ga-labeled somatostatin based receptor hybrid imaging is a potential alternative to FDG PET/CT. This short communication provides a rapid overview of initial findings concerning the application of 68Ga-labeled somatostatin based receptor hybrid imaging in the diagnosis of (cardiac) sarcoidosis activity.

U2 - 10.1186/s41824-017-0014-y

DO - 10.1186/s41824-017-0014-y

M3 - Article

C2 - 29782604

VL - 1

JO - European Journal of Hybrid Imaging

JF - European Journal of Hybrid Imaging

SN - 2510-3636

M1 - 7

ER -